The DOI matches its Crossref record; 184 of the 185 references it cites were found in a registry or an index.
Apoptosis and necroptosis in the liver: a matter of life and death
Open accessAbstract
Cell death represents a basic biological paradigm that governs outcomes and long-term sequelae in almost every hepatic disease condition. Acute liver failure is characterized by massive loss of parenchymal cells but is usually followed by restitution ad integrum. By contrast, cell death in chronic liver diseases often occurs at a lesser extent but leads to long-term alterations in organ architecture and function, contributing to chronic hepatocyte turnover, the recruitment of immune cells and activation of hepatic stellate cells. These chronic cell death responses contribute to the development of liver fibrosis, cirrhosis and cancer. It has become evident that, besides apoptosis, necroptosis is a highly relevant form of programmed cell death in the liver. Differential activation of specific forms of programmed cell death might not only affect outcomes in liver diseases but also offer novel opportunities for therapeutic intervention. Here, we summarize the underlying molecular mechanisms and open questions about disease-specific activation and roles of programmed cell death forms, their contribution to response signatures and their detection. We focus on the role of apoptosis and necroptosis in acute liver injury, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and liver cancer, and possible translations into clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A key feature of MASH is hepatocyte apoptosis, which correlates with the clinically most important feature of the disease, liver fibrosis (6, 7).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hepatocyte apoptosis is a key feature of metabolic dysfunction–associated steatohepatitis (MASH)”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
In the citing paper
“In NASH, hepatocytes undergo apoptosis, necroptosis or pyroptosis (a newly described caspase 1-dependent apoptosis observed in NASH),33 thereby initiating inflammation in several ways.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“Whilst this process has anti-inflammatory potential, as it removes intracellular content which could otherwise act as DAMPs, efferocytosis also triggers macrophages to release transforming growth factor (TGF)β.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“This signalling pathway positively and negatively modulates inflammation in a number of ways, including via the activation of HSCs, a key source of scar-producing myofibroblasts.33,41”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M. K., Watari, H., Abu-Almaaty, A. H., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,155
RetractedFerroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,328
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Cited by
Sorted by citations
Items 201–300 of 589
Terada, C., Oh, K., Tsubaki, R., Chan, B., Aibara, N., Ohyama, K., Shibata, M.-A., Wada, T., Harada‐Shiba, M., Yamayoshi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43714-0 · Cited by 25
Present and Future Perspectives in the Treatment of Liver Fibrosis
Cerrito, L., Galasso, L., Iaccarino, J., Pizzi, A., Termite, F., Esposto, G., Borriello, R., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18091321 · Cited by 29
BAX Redistribution Induces Apoptosis Resistance and Selective Stress Sensitivity in Human HCC
Funk, K., Czauderna, C., Klesse, R., Becker, D., Hajduk, J., Oelgeklaus, A., Reichenbach, F., Todt, F., Lauterwasser, J., Galle, P. R., et al. (2020) · Cancers · doi:10.3390/cancers12061437 · Cited by 25
RIP kinases and necroptosis in aging and aging-related diseases
Yang, Y., Li, X., Zhang, T., & Xu, D. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac003 · Cited by 27
Qiannan-Di, Qianqian-Jiang, Jiahui-Sun, Haowei-Fu, & Qian-Xu (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.157185 · Cited by 24
Effect of Fumonisin B1 on Proliferation and Apoptosis of Intestinal Porcine Epithelial Cells
Wang, T., Lei, H., Zhou, L., Tang, M., Liu, Q., Long, F., Li, Q., & Su, J. (2022) · Toxins · doi:10.3390/toxins14070471 · Cited by 26
Gancao decoction attenuates hepatic necroptosis via activating caspase 8 in cholestatic liver injury
Zou, B., Zhang, S., Li, F., Weng, F., Zhao, J., Jin, J., Yan, D., Xu, X., Chen, G., Liu, C., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117909 · Cited by 24
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
Fang, J., Celton‐Morizur, S., & Desdouets, C. (2023) · Cancers · doi:10.3390/cancers15143723 · Cited by 25
Zhao, B., Liang, Z., Zhang, L., Jiang, L., Xu, Y., Zhang, Y., Zhang, R., Wang, C., & Liu, Z. (2024) · Advanced Science · doi:10.1002/advs.202406080 · Cited by 23
Neira, G., Becerril, S., Valentí, V., Moncada, R., Catalán, V., Gómez‐Ambrosi, J., Colina, I., Silva, C., Escalada, J., Frühbeck, G., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.007 · Cited by 25
Yuan, Y., Li, J., Chen, M., Zhao, Y., Zhang, B., Chen, X., Zhao, J., Liang, H., & Chen, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.012 · Cited by 30
Sun, M., Liu, Q., Liang, Q., Gao, S., Zhuang, K., Zhang, Y. L., Zhang, H., Liu, K., She, G., & Xia, Q. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.109171 · Cited by 23
The Effects of Apocynin on Monosodium Glutamate Induced Liver Damage of Rats
Sahin, B., Elmas, M. A., Özakpınar, Ö. B., & Arbak, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17327 · Cited by 23
PANoptosis-like death in acute-on-chronic liver failure injury
Ye, Q., Wang, H., Chen, Y., Zheng, Y., Du, Y., Ma, C., & Zhang, Q. (2024) · Scientific Reports · doi:10.1038/s41598-023-50720-1 · Cited by 23
Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis
Zhou, G., Fu, Y., Chen, J., & Liu, P. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118018 · Cited by 23
Leclère, P. S., Rousseau, D., Patouraux, S., Guérin, S., Bonnafous, S., Gréchez‐Cassiau, A., Ruberto, A. A., Luci, C., Subramaniam, M., Tran, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69085-w · Cited by 23
Processes exacerbating apoptosis in non-alcoholic steatohepatitis
Afonso, M. B., Castro, R. E., & Rodrigues, C. M. P. (2019) · Clinical Science · doi:10.1042/cs20190068 · Cited by 25
Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury
Luo, X., Linghu, M., Zhou, X., Ru, Y., Huang, Q., Liu, D., Ji, S., Ma, Y., Luo, Y., & Huang, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.01.029 · Cited by 22
Baxter, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197256 · Cited by 22
Gromowski, T., Lukacs‐Kornek, V., & Cisowski, J. (2023) · Cancer Cell International · doi:10.1186/s12935-022-02843-0 · Cited by 25
Effects of neutrophil fate on inflammation
Xiao, Y., Yang, C. Z., Liu, W., Liu, K., Wang, Y., Xu, F., Wang, D., & Yang, Y. (2023) · Inflammation Research · doi:10.1007/s00011-023-01811-2 · Cited by 30
Zheng, Y. H., Zhang, Y., Li, Z., Shi, W., Ji, Y., Guo, Y., Huang, C., Sun, G., & Li, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113162 · Cited by 22
Amorim, R., Simões, I., Veloso, C., Carvalho, A., Simões, R., Pereira, F., Thiel, T., Normann, A., Morais, C., Jurado, A., et al. (2021) · Nutrients · doi:10.3390/nu13051723 · Cited by 21
Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics
Colella, F., Henderson, N. C., & Ramachandran, P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186421 · Cited by 25
Ya, J., Xu, Y., Wang, G., & Zhao, H. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.111957 · Cited by 21
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway
Ding, J., WenjuanYang, Jiang, Y., Ji, J., Zhang, J., Wu, L., Feng, J., Zheng, Y., Li, Y., Cheng, Z., et al. (2022) · Mediators of Inflammation · doi:10.1155/2022/5676256 · Cited by 21
Wang, C., Ma, D., Yu, H., Zhuo, Z., & Ye, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14001 · Cited by 24
Hepatic inflammation after burn injury is associated with necroptotic cell death signaling
Idrovo, J. P., Boe, D. M., Kaahui, S., Yang, W.-L., & Kovacs, E. J. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002865 · Cited by 21
Khodayar, M. J., Kalantari, H., Khorsandi, L., Ahangar, N., Samimi, A., & Alidadi, H. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06428-4 · Cited by 23
Tong, Q., Yi, M., Kong, P., Xu, L. S., Huang, W., Niu, Y., Gan, X., Zhan, H., Tian, R., & Yan, D. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02692-x · Cited by 23
Necroptosis in the pathophysiology of preeclampsia
Yu, H., Chen, L., & Du, B. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2229138 · Cited by 21
Tao, L., Xue, Y.-F., Sun, F., He, X., Wang, H., Tong, C.-C., Zhang, C., Xu, D., & Chen, X. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116914 · Cited by 20
Sanz‐García, C., McMullen, M. R., Chattopadhyay, S., Roychowdhury, S., Sen, G. C., & Nagy, L. E. (2019) · Hepatology Communications · doi:10.1002/hep4.1441 · Cited by 21
Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease
Kefala, G., & Τζιόμαλος, Κ. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1570136 · Cited by 20
Common mechanisms in pediatric acute liver failure
Mann, J. P., Lenz, D., Stamataki, Z., & Kelly, D. A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.006 · Cited by 21
Definition, diagnosis and epidemiology of acute‐on‐chronic liver failure
Hernáez, R., Li, H., Moreau, R., & Coenraad, M. J. (2023) · Liver International · doi:10.1111/liv.15670 · Cited by 19
Newcastle disease virus infection induces parthanatos in tumor cells via calcium waves
Qu, Y., Wang, S., Jiang, H., Liao, Y., Qiu, X., Tan, L., Song, C., Nair, V., Yang, Z., Sun, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012737 · Cited by 19
Kusakabe, J., Hata, K., Miyauchi, H., Tajima, T., Wang, Y., Tamaki, I., Kawasoe, J., Okamura, Y., Zhao, X., Okamoto, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.001 · Cited by 18
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
Geng, W., Liao, W., Cao, X., & Yang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13020393 · Cited by 20
A multi-omic landscape of steatosis-to-NASH progression
Xiang, L., Li, X., Luo, Y., Zhou, B., Liu, Y., Li, Y., Wu, D., Jia, L., Zhu, P., Zheng, M., et al. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac034 · Cited by 18
Rui, S., Chen, W., Cao, X., Guo, J., & Wang, J. (2020) · Natural Product Communications · doi:10.1177/1934578x20910548 · Cited by 18
Zhang, Z., Chen, M., Zhan, W., Chen, Y., Wang, T., Chen, Z.-H., Fu, Y., Zhao, G., Mao, D., Ruan, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01624-6 · Cited by 17
Zhang, J., Zhang, Q., Jin, Q., Yang, J., Lin, S., & Fan, J. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101865 · Cited by 18
Feng, Z., Chan, Y.-T., Lu, Y., Wu, J., Xing, T., Yuan, H., Feng, Y., & Wang, N. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155913 · Cited by 17
Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice
Li, X., Shao, S., Li, H., Bi, Z., Zhang, S., Wei, Y., Bai, J., Zhang, R., Ma, X., Ma, B., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15493 · Cited by 17
Zhang, Y., Li, J., Wang, Z., Chen, J., Zhao, M., Guo, C. X., Wang, T., Li, R., Zhang, H., Ma, X., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156651 · Cited by 16
van Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H. L., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E., & Holleboom, A. G. (2023) · Cancers · doi:10.3390/cancers15041308 · Cited by 17
Liu, X., Liu, H., & Deng, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s418334 · Cited by 16
Nie, C., Lan, J., Guo, H., Ouyang, Q., Zhao, Y., Wang, P., Wang, R., Li, Y., Wang, X., Fang, B., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133190 · Cited by 16
Treatment of acetaminophen-induced liver failure by blocking the death checkpoint protein TRAIL
Chen, Q., Yan, D., Zhang, Q., Zhang, G., Xia, M., Li, J., Zhan, W., Shen, E., Li, Z., Lin, L., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165583 · Cited by 16
The role of RIPK3 in liver mitochondria bioenergetics and function
Islam, T., Afonso, M. B., & Rodrigues, C. M. P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13648 · Cited by 16
Cao, P., Chen, Q., Shi, C., Pei, M., Wang, L., & Gong, Z. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174610 · Cited by 16
Chen, L., Fan, H., Chu, H., Du, F., Chen, Y., Hu, L., Li, Z., Wang, W., Hou, X., & Yang, L. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30321 · Cited by 15
Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases
Yin, K.-L., Li, M., Song, P., Duan, Y., Ye, W.-T., Tang, W., Kokudo, N., Gao, Q., & Liao, R. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00326 · Cited by 15
Otumala, A. E., Hellen, D. J., Luna, C. A., Delgado, P., Dissanayaka, A., Ugwumadu, C., Oshinowo, O. T., Islam, M. M., Shen, L., Karpen, S. J., et al. (2023) · Lab on a Chip · doi:10.1039/d2lc00940d · Cited by 17
Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases
Patankar, J. V., Bubeck, M., Acera, M. G., & Becker, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203903 · Cited by 17
Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination
Tak, J., & Kim, S. G. (2023) · Toxicological Research · doi:10.1007/s43188-023-00201-4 · Cited by 16
Yang, A. Y., Kim, K., Kwon, H. H., Leem, J., & Song, J. E. (2024) · Molecules · doi:10.3390/molecules29020419 · Cited by 15
Insights into the pathogenesis of gestational and hepatic diseases: the impact of ferroptosis
You, Y., Qian, Z., Jiang, Y., Chen, L., Wu, D., Liu, L., Zhang, F., Ning, X., Zhang, Y., & Xiao, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1482838 · Cited by 18
Methylcobalamin protects against liver failure via engaging gasdermin E
Xu, W., Wang, Y., Cui, S., Zheng, Q., Lin, Y., Cui, Q., Xie, Y., Zeng, Y., Zhang, C., Li, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-54826-6 · Cited by 16
Resveratrol ameliorates nutritional steatohepatitis through the mmu‑miR‑599/PXR pathway
Kong, L., An, X. Y., Hu, L., Zhang, S., Liu, L., Zhao, S., Wang, R., & Nan, Y. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5102 · Cited by 15
Tao, W., Yue, X., Ye, R., Nabi, F., Shang, Y., Zhu, Z., Ahmed, B. Z., & Liu, J. (2022) · Animals · doi:10.3390/ani12050569 · Cited by 15
Symphony of regulated cell death: Unveiling therapeutic horizons in sarcopenia
Peng, J., Zou, M., Zhang, Q., Liu, D., Chen, S., Fang, R., Gao, Y., Yan, X., & Hao, L. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156359 · Cited by 18
Wernberg, C. W., Ravnskjær, K., Lauridsen, M. M., & Thiele, M. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050930 · Cited by 15
Singh, V. P., Huang, E., Pathak, V., Willard, B. B., Allende, D. S., & Nagy, L. E. (2022) · Hepatology Communications · doi:10.1002/hep4.1956 · Cited by 14
Du, J., Zhang, X., Li, B., Huo, S., Zhang, J., Fu, Y., Song, M., Shao, B., & Li, Y. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171234 · Cited by 14
Sun, H.-J., Jiao, B., Wang, Y., Zhang, Y.-H., Chen, G., Wang, Z.-X., Zhao, H., Xie, Q., & Song, X. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i14.1968 · Cited by 15
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma
Tonon, F., Grassi, C., Tierno, D., Biasin, A., Grassi, M., Grassi, G., & Dapas, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212235 · Cited by 16
Schneider, A. T., Koppe, C., Crouchet, É., Papargyriou, A., Singer, M. T., Büttner, V., Keysberg, L. S., Szydlowska, M., Jühling, F., Moehlin, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56493-7 · Cited by 14
Self-citationKoppe, C., Reisinger, F., Wehr, K., Vucur, M., Trautwein, C., Tacke, F., Heikenwälder, M. F., & Luedde, T. (2019) · Cancers · doi:10.3390/cancers11070999 · Cited by 14
Self-citationEffect of endurance exercise training on liver gene expression in male and female mice
Melo, L., Tilmant, K., Hagar, A., & Klaunig, J. E. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0379 · Cited by 13
Fang, P., Sun, G., & Wang, J. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13258 · Cited by 14
Necroptosis in Solid Organ Transplantation: A Literature Overview
Lukenaite, B., Griciune, E., Leber, B., Strupas, K., Stiegler, P., & Schemmer, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073677 · Cited by 16
Schneider, L. J., Santiago, I., Johnson, B., Stanley, A. H., Penaredondo, B. A., & Lund, A. K. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115094 · Cited by 15
Lopes, M. E., Nakagaki, B. N., Mattos, M. S., Campolina-Silva, G. H., Meira, R. D. O., Paixão, P. H. D. M., de Oliveira, A. G., Faustino, L., Gonçalves, R., & Menezes, G. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892114 · Cited by 14
Fan, K., Chen, K., Zan, X., Zhi, Y., Zhang, X., Zhang, X., Qiu, J., Liu, G., Li, L., Tang, L. P., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06001-w · Cited by 13
Schisantherin A protects hepatocyte via upregulating DDAH1 to ameliorate liver fibrosis in mice
Liang, Y., Fang, J., Zhou, X., Zhang, Z., Liu, W., Hu, Y., Yu, X., Mu, Y., Zhang, H., Liu, P., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155330 · Cited by 13
Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
Borrello, M. T., & Mann, D. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15853 · Cited by 15
Amstein, L., Ackermann, J., Hannig, J., Đikić, I., Fulda, S., & Koch, I. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010383 · Cited by 14
Yan, H., Huang, X., Xu, J., Zhang, Y., Chen, J., Xu, Z., Li, H., Wang, Z., Yang, X., Yang, B., et al. (2023) · Advanced Science · doi:10.1002/advs.202302002 · Cited by 12
RETRACTED: Molecular insights into experimental models and therapeutics for cholestasis
Zhang, W., Wu, H., Luo, S., Lu, X., Tan, X., Li, W., Ma, X., & Efferth, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116594 · Cited by 12
RetractedMechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
Ni, K., & Meng, L. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102381 · Cited by 14
Petagine, L., Zariwala, M. G., Somavarapu, S., Chan, S. H. Y., Kaya, E. A., & Patel, V. B. (2025) · Scientific Reports · doi:10.1038/s41598-025-91139-0 · Cited by 12
Müller, K., Honcharova‐Biletska, H., Koppe, C., Egger, M., Chan, L. K., Schneider, A. T., Küsgens, L., Böhm, F., Boege, Y., Healy, M. E., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007194118 · Cited by 12
Self-citationWen, L., Hu, J., Zhang, J., & Yang, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12156 · Cited by 12
Downregulation of RIP3 Improves the Protective Effect of ATF6 in an Acute Liver Injury Model
Huang, M., Wan, D.-W., Deng, J. V., Guo, W., Huang, Y., Chen, H., Xu, D., Jiang, Z., Xue, Y., & He, Y.-H. (2021) · BioMed Research International · doi:10.1155/2021/8717565 · Cited by 12
Zhang, Y., Liang, X., Guan, J. Z., Jin, J., Zhang, Y., Xu, F., & Fu, J. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115929 · Cited by 12
Xinyu, W., Qian, W., Wu, Y., Kong, J., Keying, X., Jiao, J., Zhang, H., Wang, K., Xu, X., & Zhan, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06170-8 · Cited by 13
Jin, L., Kom, M. C., Fu, G., Xie, Y., Gao, Y., Shen, J., Huang, H., Hu, B., & Yan, J. (2022) · Environmental Toxicology · doi:10.1002/tox.23483 · Cited by 12
Lin, J., Xu, M., Ji, H., Huang, W., Zhou, Y., Zhou, Y., Liu, Y., Sang, Y., Qian, Y., Wu, H., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003018 · Cited by 12
Sun, C.-Y., Zhao, P., Yan, P., Li, J., & Zhao, D. (2022) · Medicina · doi:10.3390/medicina58091176 · Cited by 11
Jesenko, T., Kranjc, S., Čemažar, M., Biasin, A., Tierno, D., Scaggiante, B., Grassi, M., Grassi, C., Dapas, B., Truong, N. H., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041249 · Cited by 11
Ohene-Marfo, P., Nguyen, H. V. M., Mohammed, S., Thadathil, N., Tran, A., Nicklas, E. H., Wang, D., Selvarani, R., Farriester, J. W., Varshney, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052813 · Cited by 12
Ding, W., Fan, Y., Zhang, C., Fu, L., Chen, X., & Xu, D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.011 · Cited by 11
Tian, T., Xie, R., Ding, K., Han, B., Yang, Q., & Yang, X. Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9611 · Cited by 11
Wang, F., Tang, L., Liang, B., Jin, C., Gao, L., Li, Y., Li, Z., Shao, J., Zhang, Z., Tan, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.658811 · Cited by 11
Ma, T., Zhang, H., Li, T., Bai, J., Wu, Z., Cai, T., Chen, Y., Xia, X., Du, Y., & Fu, W. (2022) · Phytotherapy Research · doi:10.1002/ptr.7605 · Cited by 11
Lim, Y., & Ku, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126401 · Cited by 14
Xiao, F., Wang, H., Hu, J., Tao, R., Weng, X.-X., Wang, P., Wu, D., Wang, X., Yan, W., Dong, X., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i4.479 · Cited by 12
Peng, J., Wang, T., Yue, C., Luo, X., & Xiao, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1004511 · Cited by 11
Metadata
- Authors
- Schwabe, R. F., & Luedde, T.
- Affiliations
- Columbia University Irving Medical Center (US)
- Universitätsklinikum Aachen (DE)
- Corresponding author
- Schwabe, Robert F.
- Luedde, Tom
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2018-09-24
- Volume
- 15
- Issue
- 12
- Pages
- 738-752
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC6490680
- OpenAlex
- W2890337997
- Cited by
- 582
- References
- 185
- Citations by year
- 2026: 51 · 2025: 82 · 2024: 93 · 2023: 91 · 2022: 94 · 2021: 78 · 2020: 59 · 2019: 33
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Cancer Institute (R01CA190844, R01CA200597)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- apoptosis, necroptosis, programmed cell death, liver injury, acute liver failure, chronic liver disease, liver fibrosis, liver cirrhosis, liver cancer, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatic stellate cells, hepatocyte turnover, cell death detection
- MeSH terms
- Animals, Humans, Liver, Liver Diseases, Necrosis, Cell Death, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review